Pfizer announced last week that it has named general counsel and Vice Chairman Jeffrey B. Kindler as chief executive officer to replace Hank McKinnell, who will remain chairman of the board of the world's largest drug company until his retirement in February 2007. Pfizer noted that Kindler has been "responsible for many of the company's major corporate functions." Kindler joined the company in 2002, and previously served as executive vice president, corporate relations and general counsel of McDonald's.
August 01, 2006 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Pfizer Inc. said Friday it named general counsel and vice chairman Jeffrey B. Kindler as chief executive officer to replace Hank McKinnell, 63, who will remain chairman of the board of the world’s largest drug company until his retirement in February 2007.
Kindler, 51, also was elected to the drugmaker’s board. He joined New York-headquartered Pfizer in 2002 as senior vice president and general counsel, and became vice chairman in 2005.
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
